XORTX Therapeutics Inc. (NASDAQ:XRTX – Get Free Report) saw a large increase in short interest during the month of April. As of April 15th, there was short interest totaling 44,502 shares, an increase of 129.0% from the March 31st total of 19,435 shares. Approximately 3.4% of the shares of the stock are sold short. Based on an average trading volume of 187,072 shares, the short-interest ratio is presently 0.2 days.
Analysts Set New Price Targets
Separately, Weiss Ratings reiterated a “sell (e+)” rating on shares of XORTX Therapeutics in a report on Friday, March 27th. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the company currently has an average rating of “Sell”.
Read Our Latest Analysis on XRTX
XORTX Therapeutics Price Performance
XORTX Therapeutics (NASDAQ:XRTX – Get Free Report) last posted its earnings results on Thursday, February 26th. The technology company reported ($0.45) earnings per share for the quarter.
Institutional Trading of XORTX Therapeutics
An institutional investor recently raised its position in XORTX Therapeutics stock. Citadel Advisors LLC increased its position in shares of XORTX Therapeutics Inc. (NASDAQ:XRTX – Free Report) by 124.4% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 86,326 shares of the technology company’s stock after purchasing an additional 47,858 shares during the period. Citadel Advisors LLC owned approximately 1.24% of XORTX Therapeutics worth $70,000 at the end of the most recent quarter. 0.23% of the stock is currently owned by institutional investors and hedge funds.
XORTX Therapeutics Company Profile
Xyratex Ltd (Xyratex) is a provider of data storage technology, including modular solutions for the enterprise data storage industry and hard disk drive (HDD) capital equipment for the HDD industry. Xyratex operates in two segments: Networked Storage Solutions (NSS) and Storage Infrastructure (SI). Its NSS products are primarily HDD based data storage subsystems and solutions, which it provides to original equipment manufacturers. Its SI products consist of HDD manufacturing process equipment, which it sells directly to manufacturers of HDDs and their component suppliers.
Featured Articles
Receive News & Ratings for XORTX Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for XORTX Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
